Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aikaterini Sfiridaki
Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Related publications
Bone Destruction in Multiple Myeloma
Annals of the New York Academy of Sciences
Genetics
Molecular Biology
Biochemistry
Neuroscience
History
Philosophy of Science
Bone Marrow Angiogenesis in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
NEK2 Induces Osteoclast Differentiation and Bone Destruction via Heparanase in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Angiogenesis and Its Therapeutic Implication 5. Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma
Internal Medicine
Internal Medicine
Medicine
Dual Causes of Multiple Myeloma
International Journal of Case Reports and Images
Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma
British Journal of Cancer
Cancer Research
Oncology
Evaluating Biomarkers of Neuronal Degeneration and Neuroinflammation in CSF of Patients With Multiple Sclerosis–osteopontin as a Potential Marker of Clinical Severity
Journal of the Neurological Sciences
Neurology
Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
